CERo Therapeutics Holdings, Inc. Common Stock (CERO) — Tangible Net Worth Ratio
CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a Tangible Net Worth Ratio of 100.0% as of June 2023. This metric is calculated by deducting intangible assets ($0.00) from net assets ($549.25K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore CERo Therapeutics Holdings, Inc. Common (CERO) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
CERo Therapeutics Holdings, Inc. Common Stock Tangible Net Worth Ratio (2021–2022)
This chart shows how CERo Therapeutics Holdings, Inc. Common Stock's Tangible Net Worth Ratio has changed across 2 annual periods from 2021 to 2022. As of June 2023, the ratio stands at 100.0%, reflecting net assets of $549.25K with intangible assets of $0.00 USD. For live market cap and overall valuation, see CERo Therapeutics Holdings, Inc. Common stock valuation.
Annual Tangible Net Worth Ratio for CERo Therapeutics Holdings, Inc. Common Stock (2021–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for CERo Therapeutics Holdings, Inc. Common Stock from 2021 to 2022, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See CERO financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $2.47 Million | $0.00 | $42.37 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $170.83 Million | $0.00 | $180.08 Million | — |